Advertisement

Topics

Lundbeck failure in Alzheimer's reverberates

20:58 EDT 22 Sep 2016 | BioPharmaDive

The company's drug idalopirdine missed the mark in a Phase 3 study, a failure that could have repercussions for other drugs in the AD pipeline. 

Original Article: Lundbeck failure in Alzheimer's reverberates

NEXT ARTICLE

More From BioPortfolio on "Lundbeck failure in Alzheimer's reverberates"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...